Mpox Epidemiology and Risk Factors, Nigeria, 2022.

Authors: Ogoina, Dimie¹, dimieogoina@gmail.com, Dalhat, Mahmmod Muazu², Denue, Ballah Akawu³, Okowa, Mildred⁴, Chika-Igwenyi, Nneka Marian⁵, Oiwoh, Sebastine Oseghae⁶, Tobin, Ekaete Alice⁶, Yusuff, Hakeem Abiola⁷, Ojimba, Anastacia Okwudili⁸, Christian, Umenzekwe Chukwudi⁹, Aremu, John-Tunde¹⁰, Gomerep, Simji Samuel¹¹, Habila, Kambai Lalus¹², Awang, Sati Klein¹³, Adekanmbi, Olukemi¹⁴, Iroezindu, Michael¹⁵, Onukak, Asukwo¹⁶, Falodun, Olanrewaju¹⁷, Sunday, Mogaji¹⁸, Johnson, Simon Mafuka¹⁹

Source: Emerging Infectious Diseases; Sep2024, Vol. 30 Issue 9, p1799-1808, 10p

Clinical characteristics and predictors of human mpox outcome during the 2022 outbreak in Nigeria: a cohort study

Authors: Ogoina, Dimie ^*, Dalhat, Mahmood Muazu, Denue, Ballah Akawu, Okowa, Mildred, Chika-Igwenyi, Nneka Marian, Yusuff, Hakeem Abiola, Christian, Umenzekwe Chukwudi, Adekanmbi, Olukemi, Ojimba, Anastacia Okwudili, Aremu, John Tunde, Habila, Kambai Lalus, Oiwoh, Sebastine Oseghae, Tobin, Ekaete Alice, Johnson, Simon Mafuka, Olaitan, Abimbola, Onyeaghala, Chizaram, Gomerep, Simji Samuel, Alasia, Datonye, Onukak, Asukwo E, Mmerem, Juliet, Unigwe, Uche, Falodun, Olanrewaju, Kwaghe, Vivian, Awang, Sati Klein, Sunday, Mogaji, Maduka, Chiedozie James, Na'uzo, Aliyu Mamman, Owhin, Sampson Omagbemi, Mohammed, Abdullahi Asara, Adeiza, Mukhtar Abdulmajid

Source: In The Lancet Infectious Diseases December 2023 23(12):1418-1428

This result is not displayed to guests.
Login for full access.